Alira Health Welcomes Marie-Aude Ohresser, Vice President, Regulatory Affairs

News
Category:
Published on:
May 5, 2020

BOSTON, USA – Alira Health (www.alirahealth.com), a leading international healthcare and life sciences advisory firm, announces the appointment of Marie-Aude Ohresser to Vice President, Regulatory Affairs. Based in our Basel, Switzerland office, Marie-Aude will be instrumental in bolstering our EU regulatory capabilities as well as offering more comprehensive regulatory support globally.

Marie-Aude Ohresser

“We are delighted to welcome Marie-Aude to our Alira Health family. Marie-Aude joins us with a rich background and knowledge in the pharmaceutical industry including drug development, gene therapy, and various areas of regulatory affairs,” said Giacomo Basadonna, Chief Medical Officer, Alira Health. “Marie-Aude’s recruitment represents a fundamentally important step forward in expanding Alira Health’s global presence as a leading force in Regulatory Affairs for Pharma Products and Medical Devices, with the goal of transforming health care delivery for the benefit of patients around the world.”

“At this point in my career, I am ready for new challenges, and Alira Health is a perfect match for me. My new colleagues are dynamic, agile, and diligent and foster a supportive work environment,” said Marie-Aude. “I look forward to building on Alira Health’s existing pharma regulatory services as well as continuing to grow the synergies with our other divisions. I am confident that we are creating something extraordinary here, and the sky is the limit.”

Marie-Aude has over 20 years of experience in product development for the pharmaceutical industry. For the last decade, she worked with F. Hoffmann-La Roche, Ltd. as the Head of EU Liaison, Global Regulatory Affairs where she was responsible for planning and implementing strategy and activities such as optimizing resources and processes, developing KPIs, strengthening collaboration between affiliates and global regulatory departments to meet business needs. Marie-Aude has also led various cross-functional projects in the areas of regulatory records management and the pharmacovigilance system master file.

Most recently, Marie-Aude led changes related to Brexit across Roche’s pharmaceutical division. Prior to this, Marie-Aude was a regulatory strategist at Transgene SA and a project lead for a therapeutic vaccine in oncology. Marie-Aude has extensive knowledge of EU regulatory procedures and hands-on experience in preparing high-quality regulatory documentation.

To learn more about Marie-Aude, contact us.

Related news

Events May 19, 2022
DIA 2022 Global Annual Meeting
We are pleased to announce that we will be joining DIA 2022 Global Annual Meeting as exhibitors and delegates.
Biometrics Clinical Life Sciences Regulatory
Multimedia April 13, 2022
U.S. and European Regulatory Strategies for Asian MedTech Startups
This webinar will focus on the U.S. FDA and EU MDR/IVDR regulatory pathways and strategies for medical device startups based in the Asia Pacific.
MedTech Regulatory
Publications April 8, 2022
Cheat Sheet: MDCG Guidance on Medical Device Classification
Assigning the proper class to a medical device (MD) is one of the most important activities carried out by a manufacturer. Read Alira Health's cheat sheet MDCG Guidance on Medical Device(...)
MedTech Regulatory
News April 5, 2022
Alira Health Strengthens Clinical Operations with the Acquisition of Sourcia
We acquired a full-service Contract Research Organization (CRO), Sourcia, that provides services for Phase I to Phase IV clinical trials with a focus on biotech, medical devices, and(...)
Clinical MedTech Patient Engagement Pharma Regulatory Research & Development
Publications March 31, 2022
The FDA’s Project Orbis Can Speed up the Delivery of Your New Oncology Drug to Global Markets
Are you developing an oncology drug? Project Orbis, a program coordinated by the U.S. Food and Drug Administration (FDA), allows you to register your product in several countries with(...)
Pharma Regulatory
Publications March 16, 2022
European Commission’s New Regulation Amending IVDR Transitional Provisions: What You Need to Know
The European Commission (EC) has published an amendment of the IVDR, delaying the transitional period for some IVDs. However, the IVDR Date of Application remains the same, so Alira(...)
Regulatory
Events July 20, 2021
Webinar Recap: Risk Management & Regulatory Submissions
Download Alira Health's Senior Vice President, Regulatory Affairs, Mary McNamara-Cullinane's webinar presentation, How to Implement Risk Management into Regulatory Submissions Using(...)
Regulatory
Welcome to Alira Health. This site is best viewed in Chrome, Microsoft Edge, or Firefox.